Navigation Links
PDI Announces Exclusive Partnership With Qforma, Leading Provider of Advanced Analytics for Health Sciences Industry
Date:3/15/2011

PARSIPPANY, N.J., March 15, 2011 /PRNewswire/ -- PDI, Inc. (Nasdaq: PDII), a leading provider of integrated multichannel promotional outsource services to established and emerging health care companies, today announced the signing of an exclusive strategic partnership with Qforma, the leading provider of advanced analytics and predictive modeling technologies for the health sciences industry.

Through this agreement, PDI will gain access for its pharmaceutical and biotech customers to the most sophisticated modeling tools available in the industry. With this advanced technology, PDI will be able to navigate complex and disparate healthcare data with increased clarity in order to formulate coordinated responses with greater resource efficiency and effectiveness for its clients.

Nancy Lurker, Chief Executive Officer of PDI, Inc., said, "We are pleased to be partnering with industry expert Qforma to strengthen the promotional communications services we can offer to our clients. At PDI, we are driven to deliver optimal value to our customers by acquiring and adopting the most effective tools and vehicles for communicating with physicians and other health care providers."

"Qforma has developed technologies and data reservoirs that deliver focused, actionable insights to sales, managed care and marketing teams in the health sciences industry," said Kelly D. Myers, CEO of Qforma. "We look forward to working with PDI to provide strategic data visibility, quantified metrics and timely alerts to impending market change, so they can make the most effective use of their multichannel communications resources."

Qforma's analytics and technologies are expected to enhance PDI's outsource promotional services units, including its on-the-ground dedicated and shared sales teams; Group DCA, a leader in e-detailing and digital communications; Pharmakon, offering interactive peer communications programs among healthcare practitioners; PDI VOICE, providing teledetailing; and PDI's newest independent division, EngageCE, offering expert clinical educators to work with healthcare providers in managing chronic diseases in order to optimize patient care and outcomes.

About Qforma

Qforma is the leading provider of advanced analytics and predictive modeling for the health sciences industry. The company leverages the talents of health sciences executives, physicists, mathematicians and programmers, to deliver actionable insights from large disparate data. Qforma delivers powerful sales, marketing and managed care contracting solutions, including innovative physician social network technologies, to help its clients realize significant resource efficiencies.

Qforma is headquartered in Santa Fe, N.M., with offices in Princeton, N.J. More information is located at www.Qforma.com.

About PDI, Inc.

PDI, with its interactive digital agency Group DCA, is a leading provider of integrated multichannel promotional outsource services to established and emerging health care companies. The company is dedicated to enhancing engagement with health care practitioners and optimizing commercial investments for its clients by providing strategic flexibility, innovative multichannel promotional solutions, and sales and marketing expertise. For more information, please visit the company's website at http://www.pdi-inc.com.


'/>"/>
SOURCE PDI, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)... , June 23, 2016 Research and ... Global Market - Forecast to 2022" report to their ... treatment method for the patients with kidney failure, it replaces ... fluid from the patient,s blood and thus the treatment helps ... and chloride in balance. Increasing number of ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... ... 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida ... their peers for this recognition are considered among the top 2 percent of lawyers ... as members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark ...
(Date:6/24/2016)... ... 2016 , ... People across the U.S. are sharpening their pencils and honing ... contest in which patients and their families pay tribute to a genetic counselor by ... Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In ...
Breaking Medicine News(10 mins):